They’re often called the four “pillars” of cancer treatment because of their prevalence. Physicians have used surgery, chemotherapy, radiation therapy,...
While spending on oncology drugs in the U.S. is anticipated to reach $125 billion by 2027, overall drug savings of...
This white paper highlights 5 pressing challenges payers face as they attempt to enable the best outcomes for their members,...
Momentum is building for more state legislators to have health insurance companies pay for biomarker testing for patients with cancer....
If a recent LinkedIn poll is any indication, managing high drug costs associated with cancer care continues to be a...
Oncology innovations and cancer care treatment are complex, exceeding an estimated $200 billion in 2020. As cancer research constantly develops new...
The complexity of cancer care continues to increase, and payers are under pressure to balance the dramatic rise in costs...
The pandemic has forced us as an industry to reexamine how we interact and engage with our patients and how...
Learn how payers can reduce and manage the costs of cancer while driving positive outcomes for their members, their provider...
The burden of cancer and autoimmune diseases is heavy on patients, providers, and payers in the United States. Nearly 40...
Prostate cancer killed my dad. Liver cancer killed his father. My mom is fighting multiple myeloma. Her mother battled breast...
For over 10 years, Eviti Connect has empowered oncology practices and health plans to prescribe and reimburse high-quality, high-value patient care....